Sobrevida de pacientes con cáncer de mama Her2 positivo tratadas en el Hospital de Solca Loja
Breast cancer HER2 positive (BRCA HER2 +) represents 20 to 30% of breast cancers, until before biological therapies was the most aggressive, with a 5-year survival of 74%. This is why arises the need for the current research whose main objective was to determine the 5-year survival in patients with...
Guardat en:
| Autor principal: | |
|---|---|
| Format: | bachelorThesis |
| Idioma: | spa |
| Publicat: |
2019
|
| Matèries: | |
| Accés en línia: | http://dspace.unl.edu.ec/jspui/handle/123456789/22031 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
Afegir etiqueta